Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore budgeting tips that drive financial success through precise allocations, goal alignment, and disciplined spending controls.
22,313 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
JPMorgan CEO Jamie Dimon outlined a plan to fix a looming shipbuilding labor gap, arguing 300,000 skilled trades work...
Alphabet's Gemini delays raise questions about AI leadership and stock resilience. This guide analyzes what the lag m...
A federal judge dismissed a lawsuit alleging Buffalo Wild Wings misled customers with the word 'boneless wings.' The ...
Amazon tops Walmart in 2025 U.S. revenue, marking a historic shift toward tech-powered retail. The milestone could re...
As Walmart introduces a new chief executive in 2026, investors weigh whether the company can sustain growth, expand m...
Nvidia has built a fortress around AI-driven growth, but one number could alter the trajectory. This article breaks d...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
BlackRock’s DYNF uses active factor rotation to chase leadership across value, quality, momentum, and more. As market...
Netflix remains the benchmark in streaming, but rivals are accelerating with new pricing, ad tiers, and AI-driven fea...
As voice interfaces become a staple in shopping, SoundHound AI could rise as a key AI infrastructure layer. This arti...
Lamborghini posted a record year for deliveries in 2025, but import tariffs trimmed profits and narrowed margins. The...